eLearning


Then and Now: Experts’ Insights on Understanding the Women’s Health Initiative Hormone Therapy Trials

Then and Now: Experts’ Insights on Understanding the Women’s Health Initiative Hormone Therapy Trials

Release date: July 1, 2016
Expiration date: July 1, 2017
Topic: Hormone replacement therapy
Target audience: Oncologists, obstetricians and gynecologists, and other specialists and family physicians with an interest in thrombosis in women with cancer
Activity format: Panel discussion available online; also available as a radio broadcast, podcast, and PDF transcript
Credit designation: The Clinical and Patient Educators Association (CPEA) designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
View Program

Women, Thrombosis, and Cancer

Women, Thrombosis, and Cancer

Release date: December 1, 2015
Expiration date: November 23, 2017
Topics: Hematology, intensive care, oncology
Target audience: Oncologists, obstetricians and gynecologists, and other specialists and family physicians with an interest in thrombosis in women with cancer
Activity format: Patient case studies
Credit designation: 11 European CME Credits (ECMEC)

Abstract
This educational program is intended to educate healthcare practitioners who treat postmenopausal women about the accurate interpretation of data from the Women’s Health Initiative hormone therapy clinical trials, while increasing awareness that a significant amount of data exist to support the appropriate use of hormone therapy as an option for treating postmenopausal symptoms in the appropriate women.

View Program

Individualizing VTE Treatment and Prevention of Recurrence: The Place for Direct Oral Anticoagulants in VTE

Individualizing VTE Treatment and Prevention of Recurrence: The Place for Direct Oral Anticoagulants in VTE

Release date: February 8, 2016
Expiration date: This program has expired
Topic: Venous thromboembolism (VTE) and direct oral anticoagulants
Target audience: Hematologists, pulmonologists, hospitalists, internists, primary care physicians
Activity format: Online expert interview with patient cases
Credit designation: Global Education Group designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Abstract
Join Prof. Alok Khorana as he is interviewed about the place for direct oral anticoagulants in the individualization of VTE treatment and prevention of recurrence. This session will highlight the unique experience and therapeutic knowledge of Prof. Khorana, broadening listeners’ perspectives and enlightening new methods of treating, diagnosing and thinking about current medical issues related to VTE facing clinicians.

Ensuring Bias-free Continuing Professional Development

As a full provider of accredited continuing professional development (CPD) programs, we have trusted relationships with established and credible accrediting bodies in the USA, Canada, and Europe.

Read More

Engaging – Relevant – Rigorous

We deliver the most clinically relevant, engaging, and fair-balanced educational activities for clinicians and allied health professionals with the aim to advance the practice of medicine and improve patient outcomes.

Read More
CPG2Care

CPG2Care

Through CPG2Care (Clinical Practice Guideline development to effecting change at...
CPD Programs

CPD Programs

We deliver the most clinically relevant, engaging, and fair-balanced educational...
Clinical Tools

Clinical Tools

With the ubiquity of smartphones and tablets in the medical environment, CME Solutions...